Savic-Radojevic, A
This is the first preclinical study to demonstrate that semaglutide, a drug in late-stage clinical development for NASH, can reduce tumor burden in a translational mouse model of NASH-HCC
Includes: Licensed provider review and ongoing medical oversight
Many insurance providers wont approve of the drugs if the purpose of using them is for weight loss and not Type 2 diabetes
It's really hard to lose weight, and a lot of people might need a medication or surgery or another medical intervention because obesity is a disease, Jay adds
Nutrition facts Nutrition facts (Detailed data) Serving size: 1 Tablespoon (14.79 ml) Ingredients 17 ingredients Purified Water, Citric Acid, Phosphoric Acid, Malic Acid, Sucralose, Natural and Artificial Flavors, Acesulfame-K, Potassium Sorbate, Sodium Benzoate